Tag Archive for: 177Lu-PSMA-617
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T clinical trial crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy
Latest Posts
- Antibody MQI‑201: Turning Cold Tumors Hot in Advanced Cancer March 26, 2026
- Bvax in Prostate Cancer: A B‑Cell Therapy That Penetrates Immune‑Excluded Tumors March 26, 2026
- Immune‑transcriptomic correlates of response to alpha‑ versus beta‑emitting PRRT in neuroendocrine tumors March 26, 2026
- ASTX295 + Olaparib: A Targeted Strategy for BRCA2‑Mutant, TP53‑Wild‑Type Cancers March 25, 2026